Fundraising Fox

Biotech Investors & VC Firms in Global

642 firms in this list, with a median first check of $500K. 156 of them lead rounds. Generated from verified public data and updated continuously.

Bioqube Ventures
BrusselsPre-Seed–Late Stage$108K – $6.5M
17 people
First Star Ventures
CambridgePre-Seed–Seed$100K – $1M
5 people
SCI Ventures
LondonSeed–Series B
18 people
MDI Ventures
JakartaPre-Seed–Growth$500K – $75M
11 people
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
Shanda Group
Redwood CityPre-Seed–Series A
20 people
Kernel Capital
CorkSeed–Late Stage$1.1M – $5.4M
10 people
Page One Ventures
Silicon ValleyPre-Seed–Series A
4 people
WELL Ventures
VancouverSeed–Growth
16 people
Bioventures Investors
WestboroughSeed–Late Stage$15M – $100M
15 people
Genentech
South San Francisco
21 people
Research Corporation Technologies
TucsonPre-Seed–Series A
12 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Tullis Health Investors
Palm Beach GardensSeries A–Late Stage$500K – $10M
12 people
American Century Private Investments
Kansas CityGrowth
20 people
AMR Action Fund
BostonSeed–Series C
14 people
Forward Venture Capital
DenverPre-Seed–Series A$50K – $500K
2 people
Triventures
HerzliyaPre-Seed–Series A$1M – $3M
10 people
Hikma Ventures
LondonSeed–Late Stage$5M
14 people
Indico Capital Partners
LisbonSeed–Growth$250K – $10M
8 people
Quadrille Capital
ParisSeed–Late Stage
14 people
Kinled Holding
Hong KongSeed–Series A
1 person
Ligand Pharmaceuticals
JupiterLate Stage$10M – $50M
16 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.